SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
jcmm1647-sup-0001-FigS1.tifimage/tif1369KFigure S1. Evaluation of the MAb 9A12 specificity and DUX4 labeling.
jcmm1647-sup-0002-FigS2.tifimage/tif1063KFigure S2. Evaluation of MAb 9A12 specificity using DUX4 mRNA silencing.
jcmm1647-sup-0003-FigS3.tifimage/tif201KFigure S3. Immunodetection on western blot of DUX4 expression in FSHD aligned myoblasts and myotubes.
jcmm1647-sup-0004-FigS4a.tifimage/tif1260KFigure S4. Characteristics of DUX4-positive nuclei.
jcmm1647-sup-0005-FigS4b.tifimage/tif873K 
jcmm1647-sup-0006-FigS4c.tifimage/tif442K 
jcmm1647-sup-0007-FigS5a.tifimage/tif361KFigure S5. PEST sequence prediction.
jcmm1647-sup-0008-FigS5b.tifimage/tif410K 
jcmm1647-sup-0009-FigS6a.tifimage/tif398KFigure S6. Immunodetection on western blot of DUX4 expression in muscle biopsies.
jcmm1647-sup-0010-FigS6b.tifimage/tif69K 
jcmm1647-sup-0011-TableS1-S2.docxWord document48K

Table S1. Summary of data about control primary myoblasts.

Table S2. Summary of data about DUX4 expression in FSHD muscle biopsies.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.